Vietnam Liver Cancer Elimination

Detailed Budget Allocation

1. PERSONNEL: $13M (37%)

Medical Staff (5 Centers): $3.1M
12 Vietnamese doctors × 6 years

AI Consultation Team: $2.7M
45 Vietnamese AI agents × 6 years

Korean Medical Consultations: $3.9M
13,000 carriers × $300 per consultation

Support Staff: $3.3M
Admin, lab technicians, coordinators

2. INFRASTRUCTURE: $6.7M (19%)

5 Regional Centers: $2.1M
Hanoi, HCMC, Da Nang, Hai Phong, Can Tho

CT & MRI Equipment: $3M
Essential for liver cancer detection & future multi-cancer expansion

Lab Equipment: $1.6M
Blood analysis, HBV/HCV testing

3. MEDICAL SERVICES: $13M (37%)

💡 Vietnam Insurance Coverage:

Since 2019, Vietnam insurance covers 50% of HBV + HCV treatment costs.
Total treatment value: $8M (HBV $6.5M + HCV $1.5M)
Government insurance coverage: $4M
Net cash required: $4M

Screening Program: $1M
100,000 people × $10 per screening

Carrier Surveillance: $2.8M
13,000 carriers × $40 × 2 times/year × 6 years

HBV Treatment: $6.5M (program value)
Gov insurance: $3.25M | Net cash: $3.25M

HCV Treatment: $1.5M (program value)
Gov insurance: $750K | Net cash: $750K

Cancer Treatment Support: $1.2M
Early-stage treatment coordination

4. OPERATIONS: $2.5M (7%)

Marketing & Outreach: $1.3M

Administration: $1.2M

TOTAL PROGRAM VALUE (6 YEARS)

$35.2M

Complete Program Value

Vietnam Government Insurance Coverage

- $4.0M

50% of HBV ($3.25M) + HCV ($750K) treatment costs

NET CASH INVESTMENT NEEDED

$31.2M

$13M

Personnel (37%)

$6.7M

Infrastructure (19%)

$9M

Medical (37% net)

$2.5M

Operations (7%)

Investment Return Framework

As medical professionals, we have focused our planning on delivering clinical excellence and building sustainable infrastructure. We believe this creates a foundation for significant commercial success, but we welcome experienced investors to optimize the business model and identify value opportunities beyond our medical expertise.

💚 Blended Value Proposition

Social Impact (Quantifiable)

1,000 lives saved through early detection
$50M+ healthcare system savings
13,000+ carriers managed and treated
Permanent infrastructure for Vietnam

Financial Sustainability (Projected)

Break-even trajectory by Year 6
Multiple revenue streams (patient care, data, platform)
Asset-light expansion model post Year 7
Growing market ($20B Vietnam healthcare, 10% CAGR)

Strategic Value (Long-term)

Market-leading brand in cancer screening
Proprietary medical database (13,000 patients, 6 years)
Proven AI platform with regional scalability
First-mover competitive moat

📈 Path to Attractive Returns

Phase 1 (Year 1-6): Foundation building with clear milestones. Establishes credibility, infrastructure, and patient base.

Phase 2 (Year 7-10): Commercial expansion leveraging established trust. Multiple revenue streams including patient care, data partnerships, and platform licensing.

Phase 3 (Year 10+): Market leadership with options for geographic expansion, service diversification, or platform business model. Multiple exit pathways.

Expected outcome: Attractive financial returns combined with transformational social impact. Exact multiples depend on execution and commercial optimization by experienced management.

🎯 Exit Opportunities

Strategic Acquisition: Korean hospitals, regional healthcare chains, global PE healthcare funds

Public Markets: Vietnam Stock Exchange or international listing as healthcare + technology company

Secondary Sale: PE buyout after proven revenue model

Continue Private: Dividend-paying sustainable business

Partnership Approach

Our Commitment

Medical excellence, clinical outcomes, infrastructure development, regulatory compliance, and operational execution in Phase 1

Your Expertise

Commercial strategy optimization, revenue model development, exit planning, and business expansion in Phases 2-3

Together: Impact investment with attractive blended returns

Vietnam Impact

Part 4: Budget Breakdown